Joseph Hiatt
Affiliations: | University of California, San Francisco, San Francisco, CA |
Google:
"Joseph Hiatt"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Anthony Fauci | research assistant | (ImmunoTree) | |
| Alexander Marson | grad student | UCSF |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rathore U, Haas P, Easwar Kumar V, et al. (2024) CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells. Mbio. e0222223 |
| Hiatt J, Hultquist JF, McGregor MJ, et al. (2022) A functional map of HIV-host interactions in primary human T cells. Nature Communications. 13: 1752 |
| Hiatt J, Cavero DA, McGregor MJ, et al. (2021) Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins. Cell Reports. 35: 109105 |
| Bacchus-Souffan C, Fitch M, Symons J, et al. (2021) Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART. Plos Pathogens. 17: e1009214 |
| Rutishauser RL, Deguit CDT, Hiatt J, et al. (2020) TCF-1 regulates HIV-specific CD8+ T cell expansion capacity. Jci Insight |
| Gordon DE, Hiatt J, Bouhaddou M, et al. (2020) Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science (New York, N.Y.) |
| Whitman JD, Hiatt J, Mowery CT, et al. (2020) Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nature Biotechnology |
| Whitman JD, Hiatt J, Mowery CT, et al. (2020) Test performance evaluation of SARS-CoV-2 serological assays. Medrxiv : the Preprint Server For Health Sciences |
| Gordon DE, Jang GM, Bouhaddou M, et al. (2020) A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. Biorxiv : the Preprint Server For Biology |
| Gordon DE, Jang GM, Bouhaddou M, et al. (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature |